Literature DB >> 15302350

Macular pigments: their characteristics and putative role.

Nigel P Davies1, Antony B Morland.   

Abstract

The macular pigments (MP) absorb light in the blue-green region of the visible spectrum and comprise two carotenoids, lutein and zeaxanthin. In humans the concentration of MP varies widely across the normal population. There are two (not mutually exclusive) proposed roles for MP: to improve visual function and to act as an antioxidant and protect the macula from damage by oxidative stress. In this article we review the origin, spectral characteristics and ocular distribution of MP and also discuss the effect MP has on central visual function and the techniques available for measurement of MP optical density in vivo. Finally, we review the evidence for both proposed physiological roles of MP. Considering the first of these, we conclude that although MP might improve visual function in theory, to date there is no firm evidence that higher levels of MP are correlated with enhanced measures of visual performance. There is a growing body of evidence that has highlighted associations between macular disease and low levels of MP, most particularly with age-related macular degeneration (AMD) and with risk factors for AMD. However, all findings to date are associative only and there is no direct evidence for high MP levels conferring a protective effect. Increased dietary intake of MP gives rise to increased levels of serum and retinal MP. This, taken together with the associative evidence of low MP levels in disease, indicates that a potential, and perhaps serendipitous, therapeutic strategy for macular disease exists. We conclude, however, that the potential protective properties of MP will only be fully evaluated by undertaking longitudinal studies that follow initially healthy participants through to the development of macular disease. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302350     DOI: 10.1016/j.preteyeres.2004.05.004

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  14 in total

1.  Measurement of macular pigment optical density among healthy Chinese people and patients with early-stage age-related macular degeneration.

Authors:  Xue-Tao Ren; Hong Gu; Xu Han; Jun-Yan Zhang; Xue Li; Xiu-Fen Yang; Jun Xu; Torkel Snellingen; Xi-Pu Liu; Ning-Li Wang; Ning-Pu Liu
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

2.  Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS).

Authors:  Burkhard Dasch; Andrea Fuhs; Joachim Schmidt; Thomas Behrens; Astrid Meister; Juergen Wellmann; Manfred Fobker; Daniel Pauleikhoff; Hans-Werner Hense
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

3.  Estimation of macular pigment optical density in the elderly: test-retest variability and effect of optical blur in pseudophakic subjects.

Authors:  Kevin T Gallaher; Marco Mura; Wm Andrew Todd; Tarsha L Harris; Emily Kenyon; Tamara Harris; Karen C Johnson; Suzanne Satterfield; Stephen B Kritchevsky; Alessandro Iannaccone
Journal:  Vision Res       Date:  2007-03-21       Impact factor: 1.886

4.  [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].

Authors:  M Zeimer; H W Hense; B Heimes; U Austermann; M Fobker; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2009-01       Impact factor: 1.059

5.  Macular pigment optical density spatial distribution measured in a subject with oculocutaneous albinism.

Authors:  Christopher M Putnam; Pauline J Bland
Journal:  J Optom       Date:  2014-04-18

6.  The association between dark adaptation and macular pigment optical density in healthy subjects.

Authors:  Laura Patryas; Neil R A Parry; Dave Carden; Tariq Aslam; Ian J Murray
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-12       Impact factor: 3.117

7.  Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations.

Authors:  Tomas S Aleman; Artur V Cideciyan; Elizabeth A M Windsor; Sharon B Schwartz; Malgorzata Swider; John D Chico; Alexander Sumaroka; Alexander Y Pantelyat; Keith G Duncan; Leigh M Gardner; Jessica M Emmons; Janet D Steinberg; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

8.  Significant correlations of dermal total carotenoids and dermal lycopene with their respective plasma levels in healthy adults.

Authors:  Stephanie Scarmo; Brenda Cartmel; Haiqun Lin; David J Leffell; Erin Welch; Prakash Bhosale; Paul S Bernstein; Susan T Mayne
Journal:  Arch Biochem Biophys       Date:  2010-07-14       Impact factor: 4.013

Review 9.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

10.  Lutein Leads to a Decrease of Factor D Secretion by Cultured Mature Human Adipocytes.

Authors:  Yuan Tian; Aize Kijlstra; Johan Renes; Martin Wabitsch; Carroll A B Webers; Tos T J M Berendschot
Journal:  J Ophthalmol       Date:  2015-10-04       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.